Related Experiment Videos
Acute lithium toxicity--chorea, hypercalcemia and hyperamylasemia.
P P Matsis1, R A Fisher, C Tasman-Jones
1Auckland Medical School, New Zealand.
Australian and New Zealand Journal of Medicine
|December 1, 1989
Summary
Lithium carbonate, used for manic depressive illness, can cause severe side effects like confusion and choreiform movements. Dosage adjustments in elderly patients require careful monitoring due to potential adverse reactions.
Area of Science:
- Neuroscience
- Endocrinology
- Pharmacology
Background:
- Lithium carbonate is a cornerstone treatment for bipolar disorder (manic depressive illness).
- While generally safe, lithium can induce neurological and metabolic adverse effects.
- Elderly patients may exhibit altered drug metabolism and increased sensitivity to side effects.
Observation:
- A 71-year-old woman on lithium carbonate for bipolar disorder developed confusion and choreiform movements after a dosage increase.
- These symptoms resolved upon lithium discontinuation and recurred upon reintroduction.
- Serum calcium, parathyroid hormone, and amylase levels were altered during the episodes.
Findings:
- Lithium toxicity can manifest as neurological disturbances, including chorea and cognitive impairment.
- Altered calcium homeostasis and parathyroid hormone levels may be associated with lithium-induced movement disorders.
- Elevated serum amylase without pancreatitis suggests a potential metabolic link to lithium's effects.
Implications:
- This case highlights the importance of monitoring for lithium toxicity, especially in the elderly.
- Altered calcium and parathyroid hormone levels may serve as biomarkers for lithium-induced adverse events.
- Further research is needed to elucidate the mechanisms linking lithium, calcium metabolism, and movement disorders.